Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ArriVent BioPharma, Inc. is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It is focused on maximizing the potential of its lead development candidate, firmonertinib, and advancing a pipeline of novel therapeutics, such as antibody drug conjugates (ADCs), through approval and commercialization. Firmonertinib is an oral, highly brain-penetrant, and broadly active mutation-selective epidermal growth factor receptor (EGFR) inhibitor active against both classical and uncommon EGFR mutations, including PACC and exon 20 insertion mutations. It is developing ARR-217, an ADC for the treatment of gastrointestinal cancers. Its ARR-002 is a Mucin-16 (MUC16) and sodium-dependent phosphate transport protein 2b (NaPi2b) dual-target, tetravalent (2+2 format) ADC, with site-specific conjugation to vcMMAE at a drug-to-antibody ratio (DAR) of 4.
Find out what a historical investment in ARRIVENT BIOPHARMA, INC. would be worth today using our AVBP stock calculator.
Buying AVBP shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ARRIVENT BIOPHARMA, INC. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in AVBP
What is the ticker symbol of ARRIVENT BIOPHARMA, INC.?
The ticker symbol for ARRIVENT BIOPHARMA, INC. is AVBP.
How much is one share of AVBP?
One share of AVBP is valued at $11.26 as of 20 November 2026.
What is the market capitalisation of ARRIVENT BIOPHARMA, INC. AVBP?
As of 20 November 2026 ARRIVENT BIOPHARMA, INC. has a market cap of $563.78M.
What is the 52-week high for ARRIVENT BIOPHARMA, INC. stock?
The ARRIVENT BIOPHARMA, INC. 52-week high stock price is $35.83.
What is the 52-week low for ARRIVENT BIOPHARMA, INC. stock?
The ARRIVENT BIOPHARMA, INC. 52-week low stock price is $10.33.
Can I buy AVBP shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AVBP shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AVBP on Stake
Buy AVBP from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of AVBP from only US$10 with fractional shares